The UAE Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the modern healthcare infrastructure and a favourable regulatory environment that encourages investment in clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, and Biogen.
The UAE Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. It is predicted that the number of dementia patients in the UAE would grow by 1,795% by 2050. According to recent research published in the Lancet Public Health, the UAE and other Gulf nations will witness the greatest rise in the number of individuals living with dementia over the next 30 years. Stroke affects 8,000 to 10,000 people in the UAE each year, or one per hour.
Clinical trials in neurology are undertaken in the UAE for a variety of neurological disorders, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. These studies are carried out with the goal of increasing patient treatment choices and furthering our understanding of the fundamental processes of neurological illnesses. The UAE is quickly expanding its clinical trial business, which includes neurology. Many reasons are contributing to this rise, including the country's strategic position, contemporary healthcare infrastructure, and a favourable regulatory framework that fosters clinical research investment.
Numerous worldwide pharmaceutical and biotechnology firms, including Novartis, Pfizer, Biogen, and Sanofi, are conducting neurology clinical studies in the UAE. Moreover, numerous local hospitals and research institutions, including the Cleveland Clinic Abu Dhabi and the Dubai Health Authority, are undertaking neurological clinical trials. In January 2023, Abu Dhabi established a clinical trials centre to advance medical research and assist promote the city as a worldwide medical centre In collaboration with the Mayo Clinic, the centre at Sheikh Shakhbout Medical City will explore remedies for ailments after standard therapies and drugs have failed.
Market Growth Drivers
Over 400 clinical research studies are now underway in Abu Dhabi. Researchers may benefit from the UAE Genome Project, which strives to deliver preventative and personalised health care to the Emirati population, as well as the Malaffi system, which provides unified health services and patient information. The UAE has a contemporary healthcare infrastructure, a rising research community, and a regulatory framework that fosters investment in clinical research, all of which contribute to the rise of clinical trials. Moreover, the country's strategic position and huge patient population make it an appealing location for clinical trials.
There are various barriers to the expansion of clinical trials in the UAE, including a dearth of competent healthcare professionals with clinical research competence, limited research funding, and the need for increased public knowledge and education about clinical trials. Moreover, regulatory and administrative constraints might be a problem, especially for international businesses conducting clinical trials in the UAE.
1. Report Description of the UAE Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. UAE Neurology Clinical Trials Market Executive Summary
2.1 UAE Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of UAE Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. UAE Neurology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Study Design Outlook
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.3 By Indication Outlook
4.3.3 Expanded Access
5. UAE Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in UAE
8.2 Regulatory Framework in UAE
8.3 Pricing & Reimbursement Scenario in UAE Neurology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development UAE Neurology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses